Internal Reference Number: FOI_7469
Date Request Received: 05/10/2023 00:00:00
Date Request Replied To: 06/10/2023 00:00:00
This response was sent via: By Email
Request Summary: Cancer Treatment
Request Category: Private Individuals
| Question Number 1: I would be very grateful if you could please answer these questions in relation to cancer treatment. Over the last 6 months, how many patients were treated with a combination of Dabrafenib + Trametinib for the following diseases: A) Metastatic Melanoma B) Adjuvant Melanoma C) BRAF mutated Lung Cancer | |
| Answer To Question 1: Over the last 6 months, how many patients were treated with a combination of Dabrafenib + Trametinib for the following diseases: A) Metastatic Melanoma - 0 B) Adjuvant Melanoma - 0 C) BRAF mutated Lung Cancer - <5 | |
| Question Number 2: Over the last 6 months, how many patients were treated with a combination of Encorafenib (Braftovi) + Binimetnib (Mektovi) for the following diseases: A) Metastatic Melanoma B) Colorectal Cancer C) Any other indications | |
| Answer To Question 2: Over the last 6 months, how many patients were treated with a combination of Encorafenib (Braftovi) + Binimetnib (Mektovi) for the following diseases: A) Metastatic Melanoma - 0 B) Colorectal Cancer - 0 C) Any other indications - 0 | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of ¾¨Ó㴫ý Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
